Literature DB >> 1540878

Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group.

R W McDivitt1, J A Stevens, N C Lee, P A Wingo, G L Rubin, D Gersell.   

Abstract

Specific histologic types of benign breast disease (BBD) may increase breast cancer risk. The authors analyzed data from a population-based, case-control study of women aged 20 to 54 with newly diagnosed breast cancer and control subjects randomly selected from the general population. A panel of pathologists classified the histologic findings of biopsy slides for 433 women with breast cancer and 261 control subjects, all of whom had a history of biopsy for BBD, as to the presence of epithelial hyperplasia, atypia, and other histologic features. When compared with women who had never had a breast biopsy, women with BBD without hyperplasia had an odds ratio of 1.5 (95% confidence limits [CL] 1.3 to 1.9), women with hyperplasia without atypia had an odds ratio of 1.8 (CL = 1.3, 2.4), and women with hyperplasia and atypia had an odds ratio of 2.6 (CL = 1.6, 4.1). Fibroadenoma was an independent risk factor for breast cancer (odds ratio = 1.7; CL = 1.1, 2.5). These findings suggest that women with BBD with epithelial hyperplasia either with or without atypia and women with fibroadenoma should be monitored carefully because of their elevated risk for breast cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1540878     DOI: 10.1002/1097-0142(19920315)69:6<1408::aid-cncr2820690617>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Computerized Image Analysis of Clustered Microcalcifications on Mammography: Morphome- tric Comparison between Mammography and Pathology.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Atypical hyperplasia and breast cancer risk: a critique.

Authors:  L Ma; N F Boyd
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

3.  Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue.

Authors:  H Yu; E P Diamandis; M Levesque; M Giai; R Roagna; R Ponzone; P Sismondi; M Monne; C M Croce
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Model for individualized prediction of breast cancer risk after a benign breast biopsy.

Authors:  V Shane Pankratz; Amy C Degnim; Ryan D Frank; Marlene H Frost; Daniel W Visscher; Robert A Vierkant; Tina J Hieken; Karthik Ghosh; Yaman Tarabishy; Celine M Vachon; Derek C Radisky; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

5.  Biologic characteristics of premalignant breast disease.

Authors:  Kimberly Cole; Maria Tabernero; Karen S Anderson
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

6.  Fibroadenoma with an unexpected lobular carcinoma in situ: A case report and review of the literature.

Authors:  Bin Hua; Jing-Yong Xu; Lei Jiang; Zheng Wang
Journal:  Oncol Lett       Date:  2015-07-14       Impact factor: 2.967

7.  A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.

Authors:  Geoffrey C Kabat; Joan G Jones; Neal Olson; Abdissa Negassa; Catherine Duggan; Mindy Ginsberg; Rita A Kandel; Andrew G Glass; Thomas E Rohan
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

Review 8.  Clinical management of women at increased risk for breast cancer.

Authors:  V G Vogel; A Yeomans; E Higginbotham
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

Review 9.  Anatomic indicators (histologic and cytologic) of increased breast cancer risk.

Authors:  D L Page; W D Dupont
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

10.  Risk factors for histologically confirmed benign breast tumors.

Authors:  M Rautalahti; D Albanes; J Haukka; J Virtamo
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.